The discovery of hepatitis C virus (HCV) in 1989 permitted basic research to unravel critical
components of a complex life cycle for this important human pathogen. HCV is a highly …

Exciting progress has recently been made in understanding the replication of hepatitis C
virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma …

Among the many viruses that are known to infect the human liver, hepatitis B virus (HBV)
and hepatitis C virus (HCV) are unique because of their prodigious capacity to cause …

Hepatitis C virus (HCV) is a global epidemic manifested mainly by chronic infection. One
strategy that HCV employs to establish chronic infection is to use the viral Ser protease …

After the development of diagnostic tests for hepatitis A and hepatitis B viruses in the 1970s,
an additional parenterally transmitted agent responsible for the majority of …

Hepatitis C virus (HCV) is the major etiological agent of non‐A, non‐B post‐transfusion
hepatitis. Its genome, a (+)‐stranded RNA molecule of approximately 9.4 kb, encodes a …

Hepatitis C virus (HCV) is the major cause of transfusion-acquired non-A, non-B hepatitis.
HCV is an enveloped positive-sense RNA virus which has been classified as a new genus …

Hepatitis C virus (HCV) infection is a global health problem that impacts approximately 180
million individuals. Of those initially infected with HCV approximately 80% will progress to …

The hepatitis B virus (HBV) and hepatitis C virus (HCV) are noncytopathic, hepatotropic
members of the hepadnavirus (HBV) and ffavivirus (HCV) families that cause acute and …

An estimated 1% of the global human population is infected by hepatitis C viruses (HCVs),
and there are no broadly effective treatments for the debilitating progression of chronic …